A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort
- Resource Type
- Article
- Source
- In
Journal of the Formosan Medical Association June 2024 123(6):679-686 - Subject
- Language
- ISSN
- 0929-6646